Applied Biosystems Announces Joint Research Protocol with the NCI Cohort Consortium in Study of Breast and Prostate Cancer
Applied Biosystems, an Applera Corporation business, announced a joint, research protocol with the Cohort Consortium of the National Cancer Institute (NCI), one of the largest cohorts performing disease association studies. The protocol is being applied to discover inherited gene variants in research samples taken from patients with breast and prostate cancer, and assess the genetic variants and behavioral and environmental factors associated with the development of these cancers.
The NCI Cohort Consortium is using Applied Biosystems TaqMan® SNP Genotyping Assays and 7900HT Real-Time PCR Systems to identify novel inherited gene variants that may contribute to the development of these two cancers. The study combines the resources of six large prospective cohort studies across 10 centers and includes samples from more than 6,000 breast and 8,000 prostate cancer patients. The SNP genotyping assays designed by Applied Biosystems and used by the NCI Cohort Consortium will be made public to researchers online.
"Coordinating and standardizing genotyping activities across such a large-scale, multi-center consortium are essential to obtaining consistent, meaningful data," said Brian E. Henderson, M.D., Dean of the Keck School of Medicine, University of Southern California. "We believe the collaboration between Applied Biosystems and the Cohort Consortium for breast and prostate cancer serves as a model for other large-scale, genetic association studies."
"Exploring how genetic variation influences susceptibility in complex diseases, such as breast and prostate cancer, is critical to the development of effective therapies," said Dennis A. Gilbert, Ph.D., Chief Scientific Officer for Applied Biosystems. "We are excited about this opportunity to apply our genotyping tools to advance targeted medicine."
Other news from the department science
These products might interest you
qTOWER³ auto by Analytik Jena
Real-time PCR - fully automated for maximum efficiency
Compact, reliable and cost-effective qPCR thermal cycler for high throughput
CFX Opus by Bio-Rad Laboratories
Modern qPCR system: Calibration-free & networked
Ensure consistent results and flexible data management for gene expression analysis and GMO testing
Mastercycler X50 by Eppendorf
Reproducible, flexible and fast optimization of your PCR protocols
Connect up to 50 PCR cyclers to speed up your routine tasks and increase your throughput
Naica Crystal Digital PCR System by STILLA Technologies
High sensitivity and multiplexing for DNA/RNA detection and quantification-Naica Digital PCR System
Discover the potential of Crystal Digital PCR - a sensitive, fast and user-friendly solution
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic World PCR
This groundbreaking and highly versatile molecular technique of PCR allows us to amplify tiny amounts of genetic material on a large scale and analyze them in detail. Whether in medical diagnostics, forensic DNA analysis or research into genetic diseases - PCR is an indispensable tool that gives us deep insights into the world of DNA. Immerse yourself in the fascinating world of the polymerase chain reaction (PCR)!
Topic World PCR
This groundbreaking and highly versatile molecular technique of PCR allows us to amplify tiny amounts of genetic material on a large scale and analyze them in detail. Whether in medical diagnostics, forensic DNA analysis or research into genetic diseases - PCR is an indispensable tool that gives us deep insights into the world of DNA. Immerse yourself in the fascinating world of the polymerase chain reaction (PCR)!
